Company
Bain Capital is a global private equity and alternative investment firm managing buyout, credit, venture, and real estate funds across industries.
Foreign buyers acquired 326 Japanese companies for 6.2 trillion yen from January to September, more than they spent in all of last year. The yen and a tax change get the credit, but succession sales and corporate carve-outs also feed the supply.
Reality
Kubernetes creators Craig McLuckie and Joe Beda's startup Stacklok is building Mecatl, a coding-agent harness designed to run in the cloud. It pulls tool calls, session state and memory out of the agent loop so each can be put into systems an operator can manage.
Reality
Blackstone, Bain, Warburg Pincus and BGO are preparing final bids for Fuji Media's Sankei Building, valued by Fuji at about 1 trillion yen including debt. Vasanta Master Fund, holding under 1%, argues that a buyer pool that narrow leaves too little upside for shareholders.
Reality
HB Wealth, a $33 billion Atlanta RIA, is entering Texas by buying Wealth Care, a $700 million firm that advises healthcare workers. Hightower's deal for Sandy Cove, a divorce and legacy-planning specialist, shows PE-backed platforms still buying client niches in small pieces.
Reality
Bain Capital's Drew Chen said the firm's roughly $5 billion China data-centre sale was likely China's largest private equity exit in five years. At the same Singapore summit, Brookfield and Blackstone described the AI tools they now put inside industrial and financial portfolio companies to grow earnings.
Reality
The firm says intruders reached its cloud platforms in July and took names, birth dates and Social Security numbers. Google attributes the campaign to BlackFile, a Com affiliate with four extortion brands.
Reality
Toys "R" Us is opening 120 US stores this holiday season aimed partly at adults, whose toy buying rose 25% in the first half. Its former chief estimates 100 of the smaller shops would sell what a handful of the old ones did, so the season is a test of a cheap format.
Reality
The efficacy numbers behind this round are the company's own, and the top of the US payer market is close to booked. Both facts matter more than the size of the raise.
Reality